The authors present two patients with acute arterial vasospasm of the lower extremities causing marked ischemia. One patient had a history of Raynaud’s disease, the second had been taking Cafergot for migraine headaches. Both patients’s were given a test dose of intra-arterial tolazoline (50 mg). The patient with Raynaud’s disease demonstrated marked improvement diffusely and was successfully treated with overnight infusion of papaverine. The second patient, taking Cafergot, demonstrated no angiographic response to tolazoline. It was speculated that the arteries of this patient were thrombosed. The patient was successfully treated with urokinase and remained free of pain at the 15-month follow-up
Primary Raynaud’s phenomenon is common, particularly in younger women, and may be familial. Vasospas...
AbstractErgotism is a rare cause of vasospasm which occurs in 0.001–0.002% of patients receiving erg...
Introduction: Asherson's Syndrome, also defined as Catastrophic Antiphospholipid Syndrome (CAPS), re...
Background: Acute limb ischemia (ALI) requires immediate treatment to maintain limb viability and pr...
Background: Ischemic ulcerations of the distal lower extremities are a manifestation of chronic crit...
International audienceAcute limb ischemia induced by arterial vasospasm remains an exceptional situa...
ABSTRACT:The ergotamine tartrate associated with certain categories of drugs can lead to critical is...
AbstractIntroductionHereditary multiple exostosis syndrome is a rare condition which can occasionall...
Abstract Background The ergotamine tartrate associated with certain categories of drugs can lead to ...
BackgroundAcute limb ischemia (ALI), although uncommon, can present with profound symptoms, includin...
The two main causes of peripheral arterial occlusion (PAO) are embolism and thrombosis. Surgical tre...
Acute ischemia of an extremity potentially threatens limb loss and occasionally the life of the pati...
Intra--arterial thrombolysis has become the most important minimal--invasive treatment option to tre...
none6noAcute thromboembolic events appear to be frequent in patients with SARS-CoV-2 infection. We r...
Selecting treatment options in acute arterial thrombosis of the lower extremity, which threatens lim...
Primary Raynaud’s phenomenon is common, particularly in younger women, and may be familial. Vasospas...
AbstractErgotism is a rare cause of vasospasm which occurs in 0.001–0.002% of patients receiving erg...
Introduction: Asherson's Syndrome, also defined as Catastrophic Antiphospholipid Syndrome (CAPS), re...
Background: Acute limb ischemia (ALI) requires immediate treatment to maintain limb viability and pr...
Background: Ischemic ulcerations of the distal lower extremities are a manifestation of chronic crit...
International audienceAcute limb ischemia induced by arterial vasospasm remains an exceptional situa...
ABSTRACT:The ergotamine tartrate associated with certain categories of drugs can lead to critical is...
AbstractIntroductionHereditary multiple exostosis syndrome is a rare condition which can occasionall...
Abstract Background The ergotamine tartrate associated with certain categories of drugs can lead to ...
BackgroundAcute limb ischemia (ALI), although uncommon, can present with profound symptoms, includin...
The two main causes of peripheral arterial occlusion (PAO) are embolism and thrombosis. Surgical tre...
Acute ischemia of an extremity potentially threatens limb loss and occasionally the life of the pati...
Intra--arterial thrombolysis has become the most important minimal--invasive treatment option to tre...
none6noAcute thromboembolic events appear to be frequent in patients with SARS-CoV-2 infection. We r...
Selecting treatment options in acute arterial thrombosis of the lower extremity, which threatens lim...
Primary Raynaud’s phenomenon is common, particularly in younger women, and may be familial. Vasospas...
AbstractErgotism is a rare cause of vasospasm which occurs in 0.001–0.002% of patients receiving erg...
Introduction: Asherson's Syndrome, also defined as Catastrophic Antiphospholipid Syndrome (CAPS), re...